A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin

British Journal of Pharmacology
S R Hughes, S D Brain


1. The effect of the calcitonin gene-related peptide (CGRP) antagonist CGRP8-37 on responses to CGRP and other mediators was investigated in rabbit dorsal skin. 2. Blood flow changes at intradermally-injected sites were measured by a multiple site 133xenon clearance technique. CGRP8-37 had little effect on blood flow at doses up to 0.3 nmol/site, when injected alone, although a significant increase in blood flow was observed at the highest dose tested (1 nmol/site). 3. CGRP8-37 dose-dependently inhibited the increased blood flow induced by human alpha CGRP and human beta CGRP, but had no effect on equivalent vasodilator responses induced by vasoactive intestinal peptide (VIP) and prostaglandin E1 (PGE1). CGRP8-37 showed a preferential ability to inhibit alpha CGRP (IC50 0.04 nmol), when compared with beta CGRP (IC50 greater than or equal to 0.3 nmol). 4. Capsaicin, which selectively activates sensory nerves, caused a dose-dependent increase in blood flow when injected intradermally into rabbit skin. The effects of capsaicin (0.01-0.1 mumol/site) were inhibited by CGRP8-37 (0.3 nmol/site), with a partial but significant attenuation of blood flow induced by the highest dose of capsaicin. 5. Oedema formation, induced by intraderma...Continue Reading


Mar 1, 1979·British Journal of Pharmacology·T J Williams
Sep 28, 1990·Biochemical and Biophysical Research Communications·S M GardinerB Hughes
Oct 1, 1986·The Journal of Investigative Dermatology·S D BrainT J Williams
Apr 22, 1985·FEBS Letters·P H SteenberghH S Jansz
May 27, 1986·European Journal of Pharmacology·S D BrainT J Williams
Jan 3, 1985·Nature·S D BrainI MacIntyre
Sep 21, 1984·Science·M G RosenfeldR M Evans

❮ Previous
Next ❯


Jan 1, 1994·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·A FazekasD R Richardson
Sep 4, 1992·European Journal of Pharmacology·S R HughesS D Brain
Nov 24, 1995·European Journal of Pharmacology·A M ElhawaryC C Pang
Jan 1, 1992·Pharmacology & Therapeutics·D R Poyner
May 1, 1993·General Pharmacology·J Donnerer, R Amann
Apr 16, 1998·European Journal of Pharmacology·M Astin, J Stjernschantz
May 17, 2000·Burns : Journal of the International Society for Burn Injuries·L LindblomP Löwhagen Hendén
Oct 1, 1995·International Journal of Dermatology·S P RaychaudhuriE M Farber
Apr 20, 2005·Journal of Gastroenterology and Hepatology·Sumito MizuguchiMasataka Majima
Mar 1, 1993·British Journal of Pharmacology·P Newbold, S D Brain
Mar 1, 1994·British Journal of Pharmacology·M K Herbert, P Holzer
Aug 1, 1995·British Journal of Pharmacology·A M ElhawaryC C Pang
Feb 1, 1995·British Journal of Pharmacology·P Newbold, S D Brain
Mar 1, 1996·British Journal of Pharmacology·A E Tomlinson, D R Poyner
Jul 1, 1995·Canadian Journal of Physiology and Pharmacology·D F Rogers
Oct 11, 2005·Neuro-Signals·Louis Vera-Portocarrero, Karin N Westlund

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.